
Sign up to save your podcasts
Or


Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Healthcare4.7
33 ratings
Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

4,649 Listeners

4,343 Listeners

1,090 Listeners

30,199 Listeners

2,348 Listeners

334 Listeners

56,530 Listeners

226 Listeners

494 Listeners

9,527 Listeners

322 Listeners

195 Listeners

391 Listeners

608 Listeners

165 Listeners